• Home
  • >
  • Valiant Laboratories Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/BlinkxSearch/initials/v.svg Logo

Valiant Laboratories Ltd Financial Statement

Valiant Laboratories Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue33.0942.2962.51
Operating Expense35.1146.8260.93
Net Profit-1.22-3.50.79
Net Profit Margin-3.69-8.281.26
Earning Per Share-0.32-0.810.24
EBIDTA-2.28-4.331.8
Effective Tax Rate77.8329.5831.85

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Valiant Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023
Total Revenue Annual333.91
Operating Expenses Annual298.82
Operating Profit Annual39.95
Interest Annual0.25
Depreciation1.56
Net Profit Annual29
Tax Annual9.14

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Valiant Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023
Cash Flow at the Beginning1.31
Cash Flow from Operations56.05
Cash Flow from Investing-55.17
Cash Flow from Financing-0.93
Cash Flow at the End1.26

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Valiant Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023
PBDIT Margin (%)11.96
PBIT Margin (%)11.5
PBT Margin (%)-34.49
Net PROFIT Margin (%)8.68
Return On Networth / Equity (%)28.86
Return On Networth /Employed(%)23.73
Return On Assets (%)17.89
Total Debt / Equity(X)0.71
Asset Turnover Ratio (%)2.06

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Valiant Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023
Fixed Assets Annual48.12
Total Current Assets Annual150.58
Non Current Assets Annual62.39
Total Shareholders Funds Annual100.49
Total Assets Annual212.97

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Valiant Laboratories Ltd Earning Calls
Mar 2024
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Valiant Laboratories Ltd has a market capitalization of 632.63 Cr. Value Research classifies it as a Small-Cap company.

Yes, Valiant Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.32.

In FY 2023, Valiant Laboratories Ltd recorded a total revenue of approximately 182.06 Cr marking a significant milestone in the company's financial performance.

Valiant Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and -0.6% annually, respectively..

Valiant Laboratories Ltd's current PE ratio is 1976.97.

Valiant Laboratories Ltd's ROCE averaged 11.7% from the FY ending March 2023 to 2024, with a median of 11.7%. It peaked at 23.6% in March 2023, reflecting strong capital efficiency over the period..

Valiant Laboratories Ltd's latest EBIT is Rs. -0.69 Cr, surpassing the average EBIT of Rs. 18.85 Cr over the 5 years..